This work, based on the experimental and theoretical research carried out by the authors during the last decade, presents an overview of formation, stability and defect thermodynamics, crystal structure, oxygen nonstoichiometry, chemical strain and transport properties of the double perovskites REBaCo2−xMxO6−δ (RE = La, Pr, Nd, Eu, Gd, Y; M = Fe, Mn). These mixed-conducting oxides are widely regarded as promising materials for various energy conversion and storage devices. Attention is focused on (i) thermodynamics of formation and disordering, oxygen nonstoichiometry, crystal and defect structure of the double perovskites REBaCo2−xMxO6−δ, as well as their thermodynamic stability and the homogeneity ranges of solid solutions, (ii) their overall conductivity and Seebeck coefficient as functions of temperature and oxygen partial pressure and (iii) the anisotropic chemical strain of their crystal lattice. The relationships between the peculiarities of the defect structure and related properties of the double perovskites are analysed.
We present research investigations in the field of multilayer optics in X-ray and extreme ultra-violet ranges (XUV), aimed at the development of optical elements for applications in experiments in physics and in scientific instrumentation. We discuss normal incidence multilayer optics in the spectral region of “water window”, multilayer optics for collimation and focusing of hard X-ray, multilayer dispersing elements for X-ray spectroscopy of high-temperature plasma, multilayer dispersing elements for analysis of low Z-elements. Our research pays special attention to optimization of multilayer optics for projection EUV-lithography (ψ-13nm) and short period multilayer optics.
Drug carriers with intelligent functions are powerful therapeutic and diagnostic platforms in curing various diseases such as malignant neoplasms. These functions include the remote noninvasive activation of drug using physical impacts, e.g. light exposure. Combination of different therapeutic modalities (chemotherapy, photodynamic therapy, and so forth) with light-responsive carriers enables promising synergetic effect in tumour treatment. The main goal of this review article is to provide the state of the art on light-sensitive delivery systems with the identification of future directions and their implementation in tumour treatment. In particular, this article reviews the general information on the physical and chemical fundamental mechanisms of interaction between light and carrier systems (e.g. plasmonic and dielectric nanoparticles), the design of optically responsive drug carriers (plain and composite), and the mechanisms of light-driven controlled release of bioactive compounds in biological environment. The special focus is dedicated to the most recent advances in optically responsive bioinspired drug vehicles.